State of Wyoming Buys Shares of 56,651 Sotera Health Company $SHC

State of Wyoming purchased a new stake in shares of Sotera Health Company (NASDAQ:SHC) in the second quarter, according to its most recent filing with the SEC. The firm purchased 56,651 shares of the company’s stock, valued at approximately $1,006,000.

Several other institutional investors have also modified their holdings of the company. IFP Advisors Inc increased its stake in Sotera Health by 1,105.6% in the 4th quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock valued at $26,000 after purchasing an additional 1,371 shares in the last quarter. Rothschild Investment LLC purchased a new stake in Sotera Health during the fourth quarter worth $27,000. Root Financial Partners LLC grew its holdings in Sotera Health by 217.5% in the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock valued at $30,000 after purchasing an additional 1,455 shares during the last quarter. EverSource Wealth Advisors LLC grew its holdings in Sotera Health by 831.4% in the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock valued at $37,000 after purchasing an additional 2,935 shares during the last quarter. Finally, Eurizon Capital SGR S.p.A. purchased a new position in shares of Sotera Health in the fourth quarter valued at $40,000. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Performance

Sotera Health stock opened at $18.89 on Friday. Sotera Health Company has a fifty-two week low of $13.09 and a fifty-two week high of $19.85. The company has a market capitalization of $5.39 billion, a price-to-earnings ratio of 33.14 and a beta of 1.77. The stock has a fifty day moving average of $17.49 and a two-hundred day moving average of $16.34. The company has a debt-to-equity ratio of 3.33, a quick ratio of 2.55 and a current ratio of 2.80.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.02. The business had revenue of $321.38 million for the quarter, compared to the consensus estimate of $309.70 million. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The business’s revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.20 earnings per share. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, analysts anticipate that Sotera Health Company will post 0.87 EPS for the current fiscal year.

Analysts Set New Price Targets

SHC has been the subject of several research reports. Citigroup lifted their price target on Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. UBS Group set a $19.00 price objective on shares of Sotera Health in a research note on Wednesday, June 24th. JPMorgan Chase & Co. raised their target price on shares of Sotera Health from $16.00 to $18.00 and gave the company a “neutral” rating in a report on Friday, August 7th. The Goldman Sachs Group began coverage on shares of Sotera Health in a research report on Friday, June 5th. They set a “buy” rating and a $20.00 target price for the company. Finally, Weiss Ratings raised shares of Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday. Eight analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $21.50.

Insiders Place Their Bets

In other Sotera Health news, insider Michael P. Rutz sold 150,000 shares of the company’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $18.84, for a total value of $2,826,000.00. Following the transaction, the insider directly owned 334,279 shares in the company, valued at approximately $6,297,816.36. This represents a 30.97% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 15.36% of the company’s stock.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.